Dash Bio
Boston, US · Founded 2024 · Delaware corporation · 43 employees on LinkedIn · 5 known investors
Find your way into Dash Bio
108 people in our graph share verified history with the Dash Bio team — schools, employers, funds. One of them is your warm intro.
Noubar Afeyanunlockedknows Dave Johnson · together at Moderna (overlapped)
knows the team · via Moderna
knows the team · via Dash Bio
×9knows the team · via University at Albany
Dash Bio is a contract research organization (CRO) offering bioanalysis services with a technology-based, automated approach, delivering sample analysis results in days. It provides method development and validation, ELISA/MSD, LC-MS, and qPCR assays across preclinical to late-stage clinical studies for pharmaceutical and biotech companies.
Founders & leadership
Dash Bio was founded in 2024 by Dave Johnson.
DJ
AT
Alexander TallettNamed on SEC filing
Board
AS
Investors · 5
Reported raises · per SEC filings
Form D private placements$47.1M disclosed across 3 rounds · 2024–2026
▶$30MraisedJul 2026 · 9 investors · Other Health CareRule 506(b)
▶$30MraisedJul 2026 · 9 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- David JohnsonExecutive Officer, Director
- Alexander TallettExecutive Officer, Director
- Andy SmithDirector
- Offering amount
- $30M
- Amount sold
- $30M
- First sale
- Jun 2026
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
▶$11MraisedJun 2025 · 12 investors · BiotechnologyRule 506(b)
▶$11MraisedJun 2025 · 12 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- ALEXANDER TALLETTExecutive Officer, Director
- DAVID JOHNSONExecutive Officer, Director
- Amount sold
- $11M
- First sale
- Jun 2025
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
▶$6.1MraisedOct 2024 · 15 investors · BiotechnologyRule 506(b)
▶$6.1MraisedOct 2024 · 15 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- DAVID JOHNSONExecutive Officer, Director
- ALEXANDER TALLETTExecutive Officer, Director
- Amount sold
- $6.1M
- First sale
- Oct 2024
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 4
by search overlap
Plotly14 shared keywordsPlotly develops open-source data visualization libraries and analytics platforms—including its Plotly graphing library and Dash app framework—for analysts, engineers, and data scientists building interactive charts, dashboards, and data apps. It also offers AI-native and enterprise products for deploying and managing these apps in the cloud or self-hosted behind a firewall.
Dash Privacy Currency11 shared keywordsDash is a cryptocurrency and payment network for sending money globally, offering instant, low-cost, and private transactions through mobile and desktop wallets such as DashCore and DashPay. It targets everyday users seeking a simple way to send and receive digital currency across borders.
DoorDash7 shared keywordsDoorDash operates a restaurant delivery platform that connects customers with dining establishments across hundreds of cities in North America through a logistics network.
Dash Water7 shared keywordsDASH produces Pick & Mix, a customizable sparkling water bundle allowing customers to select their preferred flavors with no sugar, sweeteners, or calories.
Companies competing with Dash Bio for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Dash Bio Raises $30M in Series A Fundingfinsmes.com · Aug 2026Frequently asked questions
- What does Dash Bio do?
- Dash Bio is a contract research organization (CRO) offering bioanalysis services with a technology-based, automated approach, delivering sample analysis results in days. It provides method development and validation, ELISA/MSD, LC-MS, and qPCR assays across preclinical to late-stage clinical studies for pharmaceutical and biotech companies.
- Who founded Dash Bio?
- Dash Bio was founded by Dave Johnson in 2024.
- Who are Dash Bio's investors?
- Dash Bio's investors include Cybernetix Ventures, LifeX Ventures, Oak HC/FT, Swift Ventures, Freestyle Capital.
- How much funding has Dash Bio raised?
- Dash Bio has disclosed $47.1M raised across 3 rounds.
- Where is Dash Bio headquartered?
- Dash Bio is headquartered in Boston, US.